Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 4751-4800 of 6046 result(s).
CYDY CytoDyn Inc
10/17/2020 3:24:30 AM
Only reason i think it was more lik (4)
CYDY CytoDyn Inc
10/17/2020 3:12:54 AM
Potential path could mean many thin (8)
CYDY CytoDyn Inc
10/16/2020 3:55:57 AM
What would you do? I wouldn't annou (8)
CYDY CytoDyn Inc
10/16/2020 2:35:59 AM
Knowing who "Chris Sandburg" almost
CYDY CytoDyn Inc
10/16/2020 2:25:48 AM
The DSMB statistician is the one th
CYDY CytoDyn Inc
10/16/2020 2:00:00 AM
When NP answered my question about (1)
CYDY CytoDyn Inc
10/16/2020 1:50:44 AM
AGC specializes in putting out rese
CYDY CytoDyn Inc
10/16/2020 1:47:06 AM
Wouldn’t it be possible they were (1)
CYDY CytoDyn Inc
10/16/2020 1:25:01 AM
I just woke and it’s Ground Hog d (1)
CYDY CytoDyn Inc
10/16/2020 1:17:54 AM
I wonder if NP is as sanguine about (1)
CYDY CytoDyn Inc
10/16/2020 1:15:15 AM
After that uncertain PR - potential (3)
CYDY CytoDyn Inc
10/16/2020 1:09:24 AM
If the regulatory path forward was (9)
CYDY CytoDyn Inc
10/16/2020 1:02:25 AM
I posted that before I saw the newe
CYDY CytoDyn Inc
10/16/2020 12:50:59 AM
We get to enrollment with 5 new sit (1)
CYDY CytoDyn Inc
10/16/2020 12:44:36 AM
Agreed, they must have the DSMC rec (3)
CYDY CytoDyn Inc
10/16/2020 12:32:53 AM
We have a distributor ready to go i
CYDY CytoDyn Inc
10/16/2020 12:27:14 AM
That's urothelial carcinoma which u (2)
CYDY CytoDyn Inc
10/16/2020 12:21:07 AM
At least twice in interviews or con (6)
CYDY CytoDyn Inc
10/16/2020 12:11:11 AM
It could be OncoImmune was so close
CYDY CytoDyn Inc
10/15/2020 11:54:42 PM
Looking at the FDA guidance for EUA (1)
CYDY CytoDyn Inc
10/14/2020 8:51:29 AM
As if I haven't posted on here repe (21)
CYDY CytoDyn Inc
10/14/2020 8:30:57 AM
That says superior data can't be de (2)
CYDY CytoDyn Inc
10/13/2020 2:35:52 PM
That would seem to be this expanded
CYDY CytoDyn Inc
10/13/2020 2:20:17 PM
Lenzilumab inhibits GM-CSF, risanki (7)
CYDY CytoDyn Inc
10/13/2020 5:28:25 AM
and certainly does not have less re
CYDY CytoDyn Inc
10/13/2020 5:20:09 AM
“These findings suggest that the (2)
CYDY CytoDyn Inc
10/13/2020 3:23:05 AM
The Philippines Connection In the P (5)
CYDY CytoDyn Inc
10/12/2020 11:55:23 AM
T-cell recognition is a mych more i (3)
CYDY CytoDyn Inc
10/12/2020 9:34:15 AM
The members of the DSMC were picked (7)
CYDY CytoDyn Inc
10/12/2020 7:13:32 AM
IL-6 is ramps up as a very immediat (5)
CYDY CytoDyn Inc
10/10/2020 9:51:33 AM
What other actions does suramin ind (1)
CYDY CytoDyn Inc
10/10/2020 9:45:41 AM
From a paper I read long ago about (2)
CYDY CytoDyn Inc
10/10/2020 8:45:35 AM
When I first looked at the BBB I in (8)
CYDY CytoDyn Inc
10/10/2020 8:23:24 AM
COVID-19 is instead characterised b (12)
CYDY CytoDyn Inc
10/09/2020 12:41:17 PM
but given the need for the receptor (4)
CYDY CytoDyn Inc
10/09/2020 1:41:26 AM
p value tells you whether the clini (12)
CYDY CytoDyn Inc
10/08/2020 1:38:10 PM
Is the next drug going to take it d (4)
CYDY CytoDyn Inc
10/08/2020 10:59:23 AM
Is it possible Samantha Mottet got (10)
CYDY CytoDyn Inc
10/07/2020 12:12:47 PM
The Phase 2b/3 trial is for 390 pat (2)
CYDY CytoDyn Inc
10/07/2020 9:48:09 AM
"From all we know LL is most effect (8)
CYDY CytoDyn Inc
10/06/2020 9:12:34 PM
I fear we are going to have somethi (9)
CYDY CytoDyn Inc
10/06/2020 1:02:34 AM
NASDAQ: it was obvious to me when M (18)
CYDY CytoDyn Inc
10/06/2020 12:46:28 AM
I don’t like the government messi (10)
CYDY CytoDyn Inc
10/05/2020 10:20:36 PM
Of course not. $25? I'd consider it (16)
CYDY CytoDyn Inc
10/05/2020 11:04:40 AM
BoMRA would probably give us approv (2)
CYDY CytoDyn Inc
10/04/2020 12:42:56 PM
I think the doctors are not being f (11)
CYDY CytoDyn Inc
10/04/2020 11:59:30 AM
It looks like Trump must have taken (4)
CYDY CytoDyn Inc
10/04/2020 11:52:06 AM
Soon is quite non-specific. Seen ac (1)
CYDY CytoDyn Inc
10/04/2020 1:52:37 AM
If Dr. Jerry is a doctor he knows n (8)
CYDY CytoDyn Inc
10/03/2020 7:51:13 AM
Let me rephrase. No trial results t (1)
Go to page:
  • << First
  • < Previous
  • 95
  • 96
  • Next >

Recent Articles

  • Abbott Celebrates 407th Dividend with Stakeholder Commitment
  • Revolutionizing Pain Management with AI at Mornington Clinics
  • Gridspertise Expands Digital Data Management Capabilities
  • Offshore Wind Energy Market Projected to Reach $110 Billion
  • Exciting Developments Unfold for Netmarble's Raven2 MMORPG
  • seven x seven Hotel Trails New Horizons with Design Award
  • Aprio Expands Service Portal with Mize CPAs and Prism Group
  • Innovative Artivism Campaign Inspires Climate Action Engagement
  • Exciting Housing Innovations Announced by Government Officials
  • Mission Home Remodeling Showcases Sustainable Design Innovation
  • Bernstein Private Wealth Management Earns Top Award for UHNW Service
  • Collaborative Strategies to Combat Financial Fraud in Payments
  • Discovering the Impact of Tokenization at XRP Seoul 2025
  • Exploring the Impact of Vocational Skills on Global Prosperity
  • Empowering Skilled Tradeswomen: Paving the Future of Infrastructure
  • Celebrating Excellence: Seven x Seven Wins Prestigious Award
  • Unleashing the Future: ESR's Innovative MagSafe Accessories
  • Netarx Unveils Innovative SMS Deepfake Detection Solution
  • Mission Home Remodeling Showcases Sustainable Renovations
  • SEDOLL Revolutionizes the Adult Doll Industry with Cutting-Edge AI
  • Experience the Flavors of Peru at Mucho Gusto Festival
  • Fluorescence Cell Market Growth Forecast to Reach $6.37B
  • Exploring the Growing Landscape of Carcinoembryonic Antigen Market
  • Telix Pharmaceuticals Faces Challenges Amidst Regulatory Scrutiny
  • MT Højgaard's Enemærke & Petersen Secures New Project
  • West Bancorporation to Reveal Q3 Results and Conduct Call
  • ZOOZ Power's Historic Approval for Groundbreaking Bitcoin Strategy
  • Actelis Networks Earns Significant Order for Smart City Upgrade
  • WaterEquity Introduces Innovative Evergreen Fund for Impact
  • Sonnet BioTherapeutics to Showcase Innovative Cancer Treatments
  • InspireSemi's Thunderbird Chip Achieves Key Milestone and CEO Change
  • Cloudastructure Unveils MotionGi: A Leap in Video Technology
  • Understanding Your Rights as a KinderCare Investor: Key Points
  • Tradewinds Universal and Peppermint Hippo Forge New Paths
  • Tornator Secures Major Financing to Enhance Investment Strength
  • Investors of PubMatic Can Seek Justice Through Class Action
  • Simulations Plus: Navigating Investor Concerns Amid Impairments
  • InterCure's Strategic Move: Acquiring ISHI for Cannabis Growth
  • Tesla Inc. Investors Weigh Class Action Lawsuit: Key Points Explained
  • Fescaro Partners with TUV Nord for Better Cybersecurity Solutions
  • Heritage Distilling Transitions to New Ticker Symbol IPST
  • Unicycive Therapeutics Investors: Get Legal Support Now
  • Key Insights on Treatt Plc's Market Dealing Activities
  • Marex Group Scrutinized as Short Sellers Raise Concerns
  • LifeMD, Inc. Class Action Lawsuit: Key Updates for Investors
  • Significant Shareholder Transactions Notified by Subsea 7 S.A.
  • Emergent BioSolutions Announces $29 Million in Medical Countermeasure Orders
  • Join the Altimmune Class Action Suit by October 6, 2025
  • Incyte Corporation's Opzelura Gains FDA Approval for Kids
  • Snap Inc. Investors Encouraged to Join Class Action Today
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site